Target intelligence / Profile preview

Allergenic extract

Molecular classification
Other, Protein mixture, Glycoprotein
01

Overview

Allergenic extracts are complex mixtures of proteins, glycoproteins, and other organic molecules derived from natural sources such as pollens, dust mites, animal dander, fungi, or insect venoms (FDA, 2023). These mixtures are primarily used in allergen immunotherapy (AIT) to desensitize the immune system of individuals suffering from Type I hypersensitivities, such as allergic rhinitis and asthma (StatPearls, 2023). The biological function of these extracts in a clinical setting is to modulate the immune system toward a state of tolerance rather than hypersensitivity (J Allergy Clin Immunol, 2014). This therapeutic process involves shifting the immune response from a Th2-dominated profile to a Th1-dominated profile and inducing the production of regulatory T cells (Tregs) (PubMed, 2017). Additionally, the administration of these extracts stimulates the secretion of 'blocking' antibodies, specifically IgG4, which compete with IgE for allergen binding to prevent mast cell degranulation (WAO Journal, 2021). While highly effective, these complex mixtures present significant challenges in standardization and carry a risk of inducing severe systemic allergic reactions or life-threatening anaphylaxis (NIH, 2022).

Other names
Allergen mixtureComplex allergen mixtureEnvironmental allergenPollen extractStandardized allergenic extractVenom extract
02

Mechanism of action

Allergen immunotherapy (AIT) utilizes these extracts to induce peripheral T-cell tolerance, increase the population of regulatory T cells (Tregs), and promote a shift from a Th2-dominated to a Th1-dominated immune response, while also stimulating the production of allergen-specific IgG4 blocking antibodies (J Allergy Clin Immunol, 2014; PubMed, 2017).

03

Biological functions

Immune responseHypersensitivity inductionImmune toleranceT-cell modulation
04

Disease associations

Allergic rhinitisAsthmaAtopic dermatitisAnaphylaxisAllergyConjunctivitis
05

Safety considerations

AnaphylaxisSystemic allergic reactionsLocal injection site reactionsOral mucosal swellingEosinophilic esophagitis
06

Interacting drugs

Omalizumab

5 more in the full profile.

07

Biomarkers

Allergen-specific IgE (sIgE)Allergen-specific IgG4 (sIgG4)Skin prick test (SPT) reactivityBasophil activation test (BAT)

Beyond the preview

Go deeper on Allergenic extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allergenic extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call